ABCL
ABCL
CA00288U1066
AbCellera Biologics Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 75.128.000 28.833.000
160.6%
Cost of Revenue -- --
--
Gross Profit -- 28.833.000
--
278.341.000 329.979.000
15.6%
Operating Income -203.213.000 -301.146.000
32.5%
Pretax Income -177.595.000 -200.395.000
11.4%
Net Income Common Stockholders -146.412.000 -162.857.000
10.1%
-- --
--
-- --
--
ende